PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it will present at the Rodman & Renshaw 10th Annual Healthcare Conference, to be held on November 10-12 at The Palace Hotel in New York City.
